We are advising Amulet Capital Partners and SSI Strategy on the sale

Davis Polk is advising Amulet Capital Partners and SSI Strategy on the sale of SSI to Clinigen. Financial terms of the transaction were not disclosed.

Amulet Capital Partners is a middle-market private equity investment firm based in Greenwich, Connecticut, and Walnut Creek, California, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in healthcare companies, focusing on those segments it believes have the most attractive long-term fundamentals. Amulet currently manages approximately $3.1 billion in assets and is investing out of its third fund, which was oversubscribed and closed in July 2024 with approximately $1.2 billion in capital commitments.

SSI Strategy is dedicated to building better biotechs by combining sharp business acumen with deep expertise in clinical development and operations, regulatory affairs, pharmacovigilance, medical affairs and quality. With an adaptive model that scales to each client’s needs, SSI works as an embedded extension of internal teams – empowering employees, enhancing performance and accelerating progress. From concept to commercialization, SSI delivers the strategic insight, technical expertise and collaborative support biotech leaders need to overcome challenges and bring life-saving therapies to patients. SSI Strategy is headquartered in Morristown, New Jersey, with offices in London, Munich and Stockholm.

The Davis Polk corporate team includes partners Thomas J. Malone and Harold Birnbaum and associate Steven Jaffe. Partner Robert F. Smith and counsel Yuko Sin are providing sponsor finance advice. Partner Ethan R. Goldman is providing tax advice. Partner David R. Bauer is providing intellectual property advice. Partner Veronica M. Wissel is providing executive compensation advice. Partners Jesse Solomon and Matthew Yeowart are providing antitrust and competition advice. Members of the Davis Polk team are based in the New York, Washington DC and London offices.

Copy link to share post